Phathom Pharmaceuticals, Inc. PHAT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-10-25
Chart by TradingView
4/9
Piotroski F — financial health
-21.03
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $175.1M | $55.3M | $682,000 | $0 | — |
| Gross profit | $152.5M | $47.3M | $515,000 | $0 | — |
| Operating income | -$160.0M | -$277.5M | -$167.3M | -$172.4M | -$135.1M |
| Net income | -$221.2M | -$334.3M | -$201.6M | -$197.7M | -$143.9M |
| Operating cash flow | -$166.8M | -$266.8M | -$137.6M | -$146.5M | -$148.5M |
| Free cash flow | -$167.0M | -$266.9M | -$139.2M | -$147.6M | -$148.8M |
| Total assets | $259.1M | $378.3M | $413.8M | $164.8M | $189.4M |
| Total liabilities | $697.3M | $631.9M | $486.6M | $239.6M | $117.3M |
| Shareholders' equity | -$438.2M | -$253.6M | -$72.8M | -$74.8M | $72.2M |
| Ratios | |||||
| Gross margin | 87.1% | 85.6% | 75.5% | — | — |
| Operating margin | -91.4% | -502.2% | -24532.6% | — | — |
| Net margin | -126.3% | -605.1% | -29558.9% | — | — |
| FCF margin | -95.4% | -483.1% | -20412.6% | — | — |
| Return on assets | -85.4% | -88.4% | -48.7% | -120.0% | -76.0% |
| Return on equity | 50.5% | 131.8% | 277.1% | 264.3% | -199.4% |
| Debt / equity | -0.48× | -0.79× | -1.89× | -1.27× | 1.24× |
| Current ratio | 1.73 | 4.20 | 10.25 | 6.12 | 9.86 |
| Revenue growth | 216.9% | 8001.5% | — | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 305,800 | $3.4M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -21.03 (distress)
- Working capital / assets 0.374
- Retained earnings / assets -5.727
- EBIT / assets -0.617
- Equity / liabilities -0.628
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001783183 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.